Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230316 | SCV000289728 | benign | Hereditary pancreatitis | 2022-01-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000230316 | SCV001157236 | uncertain significance | Hereditary pancreatitis | 2023-02-23 | criteria provided, single submitter | clinical testing | The CTRC c.-59C>T variant (rs183658182) has been reported in pancreatitis patients (Ballard 2015, Masson 2008), but not at a significantly higher frequency compared to unaffected individuals. This variant is found in the non-Finnish European population with an allele frequency of 0.337% (52/15,428 alleles) in the Genome Aggregation Database. This variant occurs in the 5' untranslated region at a nucleotide that is weakly conserved and does not create a novel protein translation start codon. Due to limited information, the clinical significance of this variant is uncertain at this time. References: Ballard DD et al. Evaluating Adults With Idiopathic Pancreatitis for Genetic Predisposition: Higher Prevalence of Abnormal Results With Use of Complete Gene Sequencing. Pancreas. 2015 Jan;44(1):116-21. PMID: 25251442. Masson E et al. Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis. Hum Genet. 2008 Feb;123(1):83-91. PMID: 18172691. |
Ambry Genetics | RCV000230316 | SCV002657542 | likely benign | Hereditary pancreatitis | 2018-09-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000230316 | SCV002790191 | uncertain significance | Hereditary pancreatitis | 2021-12-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004691115 | SCV005186478 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003982975 | SCV004797128 | uncertain significance | CTRC-related disorder | 2024-02-21 | no assertion criteria provided | clinical testing | The CTRC c.-59C>T variant is located in the 5' untranslated region. This variant was reported in four individuals with idiopathic chronic pancreatitis, one individual with familial chronic pancreatitis, and one individual with hereditary pancreatitis but was also found in two controls (Table 4, Masson et al. 2008. PubMed ID: 18172691). This variant was also reported in two individuals with unexplained pancreatitis, although one individual also carried a CFTR variant (Supplementary Table, Ballard et al. 2015. PubMed ID: 25251442). This variant is reported in 0.34% of alleles in individuals of European (Non-Finnish) descent in gnomAD, including one homozygous individual, and has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from benign to uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/240761/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |